Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

Learn more

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

Search

Updated Prior Authorization Criteria for Burosumab-Twza (Crysvita)

Date: August 20, 2025

Attention: All Providers

Effective dates: October 1, 2025

Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective for dates of service on or after October 1, 2025, Texas Medicaid will update initial prior authorization criteria for burosumab-twza (Crysvita) (procedure code J0584).

The Texas Medicaid & Healthcare Partnership (TMHP) may consider prior authorization for clients with a diagnosis of:

  • X-linked hypophosphatemia (XLH) (diagnosis code E8331 or E8339).
  • FGF23-related hypophosphatemia caused by an underlying tumor that cannot be located or removed with surgery (diagnosis code M838).

Next steps: Providers should share this communication with their staff. 

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into: www.texaschildrenshealthplan.org/provideralerts.